SG Americas Securities’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,036
Closed -$649K 3377
2026
Q1
$649K Buy
34,036
+6,908
+25% +$153K ﹤0.01% 2032
2025
Q4
$656K Buy
27,128
+15,697
+137% +$411K ﹤0.01% 2332
2025
Q3
$292K Buy
+11,431
New +$271K ﹤0.01% 2505
2025
Q2
Sell
-19,136
Closed -$437K 2966
2025
Q1
$437K Buy
19,136
+3,405
+22% +$89.7K ﹤0.01% 1887
2024
Q4
$408K Sell
15,731
-1,257
-7% -$31.3K ﹤0.01% 1516
2024
Q3
$425K Buy
+16,988
New +$401K ﹤0.01% 1832
2023
Q2
Sell
-12,058
Closed -$262K 2348
2023
Q1
$262K Buy
+12,058
New +$271K ﹤0.01% 2213
2022
Q4
Sell
-6,323
Closed -$144K 3072
2022
Q3
$144K Sell
6,323
-7,392
-54% -$158K ﹤0.01% 2575
2022
Q2
$189K Sell
13,715
-5,797
-30% -$85.1K ﹤0.01% 2706
2022
Q1
$444K Buy
+19,512
New +$514K ﹤0.01% 1959
2021
Q4
Sell
-30,292
Closed -$1.28M 3394
2021
Q3
$1.28M Buy
+30,292
New +$1.46M 0.01% 1687
2021
Q2
Sell
-6,298
Closed -$227K 2869
2021
Q1
$227K Buy
6,298
+2,685
+74% +$106K ﹤0.01% 2593
2020
Q4
$144K Sell
3,613
-53,233
-94% -$1.82M ﹤0.01% 2839
2020
Q3
$1.65M Buy
+56,846
New +$1.23M 0.01% 865

Other funds holding BLFS

SG Americas Securities's BLFS Position: Q2 2026 in Review

SG Americas Securities sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 34,036 shares — an estimated $649K sold.

SG Americas Securities first reported a position in BLFS in Q3 2020 and held it in 14 quarters. The position peaked at $1.65M in Q3 2020. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • SG Americas Securities reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 34,036 BioLife Solutions shares in Q2 2026, an estimated $649K.
  • SG Americas Securities first reported a position in BioLife Solutions in Q3 2020 and held it in 14 quarters.
  • SG Americas Securities's BioLife Solutions position peaked at $1.65M in Q3 2020.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.